Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 12,464 | 8,658 | 6,087 | 6,726 | 5,939 | 4,443 |
| Revenue growth | 44.0% | 42.2% | -9.5% | 13.3% | 33.7% | |
| Cost of goods sold | 802 | 625 | 605 | 732 | 454 | 506 |
| Gross profit | 11,662 | 8,033 | 5,482 | 5,994 | 5,485 | 3,937 |
| Gross margin | 93.6% | 92.8% | 90.1% | 89.1% | 92.4% | 88.6% |
| General and administrative | 837 | 735 | 568 | 743 | 304 | 366 |
| EBIT | 3,853 | 1,519 | 183 | 598 | 1,694 | 1,068 |
| EBIT margin | 30.9% | 17.5% | 3.0% | 8.9% | 28.5% | 24.0% |
| Pre-tax income | 3,560 | 1,239 | -5,730 | 315 | 1,163 | 1,430 |
| Income taxes | -77 | -177 | 367 | 81 | 94 | 603 |
| Tax rate | | | | 25.7% | 8.1% | 42.2% |
| Net income | 3,637 | 1,416 | -6,097 | 234 | 1,069 | 827 |
| Net margin | 29.2% | 16.4% | -100.2% | 3.5% | 18.0% | 18.6% |
| |
| Diluted EPS | $14.08 | $5.32 | ($23.47) | $0.90 | $5.57 | $4.25 |
| Shares outstanding (diluted) | 258 | 266 | 260 | 261 | 192 | 195 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|